In this issue:
VTE in cancer patients portends a poor prognosis
Post VTE complications adversely impact QoL in elderly patients
Mutated FVL and non-O blood type increase VTE risk in cancer patients
Promising safety and pharmacokinetics for Mim8 bispecific in phase 1
Dynamic and functional linkage between VWF and ADAMTS-13 with aging
FVIII regulates VWF homeostasis in vivo
Fibrinogenolysis and fibrinolysis in VITT
Intranasal delivery of coagulation FIX feasible
Predelivery ETP levels may predict severe postpartum haemorrhage
Warfarin bests DOACs in valvular AF
Please login below to download this issue (PDF)